UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 820

Sortiert nach

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

Journal of the American College of Cardiology, 2009-11, Vol.54 (22), p.2023-2031

2009

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data

PLoS medicine, 2018-03, Vol.15 (3), p.e1002538-e1002538

2018

Link zum Volltext

Verfügbarkeit prüfen

Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT

Journal of the American Heart Association, 2019-08, Vol.8 (15), p.e012277-e012277

2019

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses

PLoS medicine, 2016-03, Vol.13 (3), p.e1001971-e1001971

2016

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis

PLoS medicine, 2021-06, Vol.18 (6), p.e1003599-e1003599

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker

PloS one, 2021-11, Vol.16 (11), p.e0260107

2021

Link zum Volltext

Verfügbarkeit prüfen

Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study

American journal of hypertension, 2017-09, Vol.30 (9), p.914-922

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study

Journal of the American Heart Association, 2019-04, Vol.8 (8), p.e011961-e011961

2019

Link zum Volltext

Verfügbarkeit prüfen

Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis

Drugs & aging, 2015-08, Vol.32 (8), p.649-661

2015

Link zum Volltext

Verfügbarkeit prüfen

Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLE

Diabetes care, 2024-01, Vol.47 (1), p.52-53

2024

Link zum Volltext

Verfügbarkeit prüfen

Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia

PloS one, 2016-10, Vol.11 (10), p.e0164364-e0164364

2016

Link zum Volltext

Verfügbarkeit prüfen

Association between chlorthalidone treatment of systolic hypertension and long-term survival

JAMA : the journal of the American Medical Association, 2011-12, Vol.306 (23), p.2588

2011

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification of sudden cardiac death in hypertension

Journal of electrocardiology, 2017-11, Vol.50 (6), p.798-801

2017

Link zum Volltext

Verfügbarkeit prüfen

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials

BMC medical research methodology, 2021-10, Vol.21 (1), p.218-218, Article 218

2021

Link zum Volltext

Verfügbarkeit prüfen

The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT–Medicare linked data

Frontiers in cardiovascular medicine, 2023-11, Vol.10, p.1272385-1272385

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended

International journal of hypertension, 2021-12, Vol.2021, p.2261144-15

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Hypertension (Dallas, Tex. 1979), 2012-05, Vol.59 (5), p.926-933

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit‐to‐Visit Variability of Blood Pressure: Results From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial

The journal of clinical hypertension (Greenwich, Conn.), 2014-05, Vol.16 (5), p.323-330

2014

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study

PloS one, 2012-03, Vol.7 (3), p.e34217

2012

Link zum Volltext

Verfügbarkeit prüfen

Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

American journal of kidney diseases, 2008-09, Vol.52 (3), p.412-424

2008

Link zum Volltext

Verfügbarkeit prüfen

Treatment Resistant Hypertension and Outcomes based on Randomized Treatment Group in ALLHAT

The American journal of medicine, 2017-04, Vol.130 (4), p.439-448.e9

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR

Clinical journal of the American Society of Nephrology, 2012-06, Vol.7 (6), p.989-1002

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial

JAMA internal medicine, 2017-07, Vol.177 (7), p.955

2017

Link zum Volltext

Verfügbarkeit prüfen

A Dynamic Risk Model for Multitype Recurrent Events

American journal of epidemiology, 2023-04, Vol.192 (4), p.621-631

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 820

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(749)
Mit Volltextzugriff
(683)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(556)
Life Sciences & Biomedicine
(485)
Humans
(436)
Female
(310)
Male
(297)
Middle Aged
(211)
Biological And Medical Sciences
(201)
Aged
(185)
Medical Sciences
(177)
Cardiovascular System & Cardiology
(124)
Hypertension - Drug Therapy
(107)
Adult
(103)
Treatment Outcome
(98)
General & Internal Medicine
(97)
Risk Factors
(95)
Antihypertensive Agents - Therapeutic Use
(92)
Medicine, General & Internal
(92)
Hypertension
(87)
Double-Blind Method
(76)
Cardiac & Cardiovascular Systems
(75)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data

Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHAT

Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis

Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker

Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study

Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study

Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis

Aspirin Dosing in Cardiovascular Disease and Diabetes: Insights From ADAPTABLE

Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia

Association between chlorthalidone treatment of systolic hypertension and long-term survival

Risk stratification of sudden cardiac death in hypertension

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials

The 18-year risk of cancer, angioedema, insomnia, depression, and erectile dysfunction in association with antihypertensive drugs: post-trial analyses from ALLHAT–Medicare linked data

Effects of Posttrial Antihypertensive Drugs on Morbidity and Mortality: Findings from 15-Year Passive Follow-Up after ALLHAT Ended

Clinical Significance of Incident Hypokalemia and Hyperkalemia in Treated Hypertensive Patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit‐to‐Visit Variability of Blood Pressure: Results From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial

Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study

Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Treatment Resistant Hypertension and Outcomes based on Randomized Treatment Group in ALLHAT

Long-Term Renal and Cardiovascular Outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants by Baseline Estimated GFR

Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults: The ALLHAT-LLT Randomized Clinical Trial

A Dynamic Risk Model for Multitype Recurrent Events

Suchergebnisse filtern